David Grainger is a biotech entrepreneur and Partner at Medicxi based in Cambridge, UK, specializing in virtual, asset-centric R&D. He is recognized for promoting innovative therapeutic development models and has a notable presence in the biotech community through thought leadership and advocacy for accelerated drug discovery.

‌